Bacterial and inflammatory behavior of implants in the early healing phase of chronic periodontitis

Quintessence International

Volumn 43, Issue 6, 2012, Pages 491-501

  Cosgarea, Raluca ^a,b   Dannewitz, Bettina ^b   Sculean, Anton ^c   Bran, Simion ^a   Rotaru, Horatiu ^a   Baciut, Grigore ^a   Eick, Sigrun ^c  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bacteria; Early healing; Implants; Inflammation; Periodontitis

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOCYTE ELASTASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SLPI PROTEIN, HUMAN;

ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL LOAD; BACTERIUM; BACTEROIDES; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; FUSOBACTERIUM NUCLEATUM; GINGIVA BLEEDING; GINGIVITIS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; MALE; MICROBIOLOGY; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PORPHYROMONAS GINGIVALIS; TOOTH; TOOTH IMPLANT; TOOTH PLAQUE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; BACTERIA; BACTERIAL LOAD; BACTEROIDES; BIOLOGICAL MARKERS; CHRONIC PERIODONTITIS; DENTAL IMPLANTS; DENTAL PLAQUE; FEMALE; FOLLOW-UP STUDIES; FUSOBACTERIUM NUCLEATUM; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PORPHYROMONAS GINGIVALIS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; TOOTH;

EID: 84867875558     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Buser D, Meriscke-Stern R, Bernard JP, et al. Longterm evaluation of non-submerged ITI implan. Part I: 8-year life table analysis of a prospective multi-center study with 2,359 implants. Clin Oral Implants Res 1997;8: 161-172.
2. Pikner SS, Gröndal K, Jemt T, Friberg B. Marginal bone loss at implants: A retrospective, long-term follow-up of turned Brånemark System implants. Clin Implant Dent Relat Res 2009;11: 11-23.
3. Lekholm U, Gröndahl K, Jemt T. Outcome of oral implant treatment in partially edentulous jaws followed 20 years in clinical function. Clin Implant Dent Res 2006;8: 178-186.
4. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. Part I. Success criteria and epidemiology. Eur J Oral Sci 1998;106: 527-551.
5. Roos-Jansåker AM, Renvert H, Lindahl C, Renvert S. Nine- to fourteen-year follow-up of implant treatment. Part III: Factors associated with peri-implant lesions. J Clin Periodontol 2006;33: 296-301.
6. De Boever AL, De Boever JA. Early colonization of nonsubmerged dental implants in patients with a history of advanced aggressive periodontitis. Clin Oral Implants Res 2006;17: 8-17.
7. Quirynen M, Vogels R, Peters W, van Steenberghe D, Naert I, Haffajee AA. Dynamics of initial subgingival colonization of ‘pristine’ peri-implant pockets. Clin Oral Implants Res 2006;17: 25-37.
8. Mombelli A, van Osten MA, Schurch E Jr, Lang NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987;2: 145-151.
9. Brägger U, Bürgin W, Hämmerle CHF, Lang NP. Associations between clinical parameters assessed around implants and teeth. Clin Oral Implants Res 1997;8: 412-421.
10. Karoussis IK, Bragger U, Salvi GE, Burgin W, Lang NP. Effect of implant design on survival and success rates of titanium oral implants: A 10-year prospective cohort study of the ITI Dental Implant System. Clin Oral Implants Res 2004;15: 8-17.
11. Brägger U. Maintenance, monitoring, therapy of failures. In: Lang NP, Karing T (eds). Proceedings of the 1st European Workshop on Periodontology. London: Quintessence, 1993;345-364.
12. Vered Y, Zini A, Mann J, et al. Teeth and implant surroundings: Clinical health indices and microbiologic parameters. Quintessence Int 2011;42: 339-344.
13. Quirynen M, Vogels R, Pauwels M, et al. Initial subgingival colonization of pristine pockets. J Dent Res 2005;84: 340-344.
14. Zambon JJ. American Academy of Periodontology. Consensus report periodontal disease. Microbial factors. Ann Periodontol 1995;67: 879-925.
15. Loomer PM. Microbiological diagnostic testing in the treatment of periodontal diseases. Periodontol 2000 2004;34: 49-56.
16. Perala D, Chapman R, Gelfand J, Callahan M, Adams D, Lie T. Relative production of IL-1β and TNF-α by mononuclear cells after exposure to dental implants. J Periodontol 1992;63: 426-430.
17. Kao R, Curtis D, Richard D, Preble J. Increased interleukin-1beta production in the crevicular fluid of dental implants. Int J Oral Maxillofac Implants 1995; 10: 696-701.
18. Gowen M, Mundy GR. Actions of recombinant IL-1 IL-2 and interferon-γ on bone resorption in vitro. J Immunol 1986;136: 2478-2482.
19. Tatakis DN, Schneeberger G, Dziak R. Recombinant interleukin-1 stimulates prostaglandin E2 production by osteoblastic cells: Synergy with parathyroid hormone. Calcif Tissue Int 1998;42: 358-362.
20. Engebretson SP, Grbic JT, Singer R, Lamster IB. IL-1beta profiles in periodontal disease. J Clin Periodontol 2002;29: 48-53.
21. Ishihara Y, Nishihara T, Kuroyanagi T, et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist level in periodontally healthy and diseased sites. J Periodont Res 1997;32: 524-529.
22. Ataoglu H, Alptekin NO, Haliloglu S, et al. Interleukin-1β and tumor necrosis factor-α levels and neutrophil elastase activity in peri-implant crevicular fluid. Correlation with clinical parameters and effect of smoking. Clin Oral Implants Res 2002;13: 470-476.
23. Baggiolini M, Walz A, Kunkel SL. Neutrophilactivating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049.
24. Schierano G, Bellone G, Cassarino E, Pagano M, Preti G, Emanuelli G. Transforming growth factor-beta and interleukin 10 in oral implant sites in humans. J Dent Res 2003;82: 428-432.
25. Liskmann S, Vihalemm T, Salum O, Zilmer K, Fischer K, Zilmer M. Correlations between clinical parameters and interleukin-6 and interleukin-10 levels in saliva from totally edentulous patients with peri-implant disease. Int J Oral Maxillofac Implants 2006;21: 543-550.
26. Starkey PM, Barrett AJ, Burleigh PM. Degradation of articular collagen by neutrophil proteinases. Biochim Biophys Acta 1977;483: 386-397.
27. Watanabe H, Hattori S, Katsuda S, Nakanishi I, Nagai Y. Human neutrophil elastase: Degradation of basement membrane components and immunolocalization in the tissue. J Biochem 1990;108: 753-759.
28. Eley BM, Cox SW. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid: Correlation with clinical parameters in untreated chronic periodontitis patient. J Periodontal Res 1992;27: 62a-69a.
29. Eley BM, Cox SW. Correlation of gingival crevicular fluid proteases with clinical and radiological measurements of periodontal attachment loss. J Dent 1992;20: 90b-99b.
30. Fritz H. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Biol Chem Hoppe Seyler 1988;369: 79-82.
31. Ohlsson M, Rosengren M, Tegner H, Ohlsson K. Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe Seylers Z Physiol Chem 1983;364: 1323-1328.
32. Into T, Inomata M, Kanno Y, et al. Arginine-specific gingipains from Porphyromonas gingivalis deprive protective functions of secretory leucocyte protease inhibitor in periodontal tissue. Clin Exp Immunol 2006;145: 545-554.
33. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25: 229-235.
34. O’Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol 1972;43: 38-42.
35. Guentsch A, Kramesberger M, Sroka A, Pfister W, Potempa J, Eick S. Comparison of gingival crevicular fluid sampling methods in patients with severe chronic periodontitis. J Periodontol 2011;82: 1051-1060.
36. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996;11: 266-273.
37. Tran SD, Rudney JD. Improved multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans, Bacteroides forsythus, and Porphyromonas gingivalis. J Clin Microbiol 1999;37: 3504-3508.
38. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4: 1-6.
39. Fürst MM, Salvi GE, Lang NP, Persson GR. Bacterial colonisation immediately after installation on oral titanium implants. Clin Oral Implants Res 2007;18: 501-508.
40. Salvi GE, Fürst MM, Lang NP, Persson GR. One-year bacterial colonization patterns of Staphylococcus aureus and other bacteria at implants and adjacent teeth. Clin Oral Implants Res 2008;19: 242-248.
41. Baba A, Abe N, Kadowaki T, et al. Arg-gingipain is responsible for the degradation of cell adhesion molecules of human gingival fibroblasts and their death induced by Porphyromonas gingivalis. Biol Chem 2001;382: 815-824.
42. Meijndert L, van der Reijden WA, Raghoebar GM, Meijer HJA, Vissink A. Microbiota around teeth and dental implants in periodontally healthy, partially edentulous patients: Is pre-implant microbiological testing relevant? Eur J Oral Sci 2010;118: 357-363.
43. Hultin M, Gustafsson A, Hallström H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002;13: 349-358.
44. Leonhardt A, Grondahl K, Bergstrom C, Lekholm U. Long-term follow-up of osseointegrated titanium implants using clinical, radiographic and microbiological parameters. Clin Oral Implants Res 2002; 13: 127-132.
45. Lachmann S, Kimmerle-Müller E, Axmann D, Scheideler L, Weber H, Haas R. Associations between peri-implant crevicular fluid volume, concentrations of crevicular inflammatory mediators, and composite IL-1A -889 and IL-1B +3954 genotype. A cross-sectional study on implant recall patients with and without clinical signs of peri-implantitis. Clin Oral Implants Res 2007;18: 212-223.
46. Melo RF, Lopes BMV, Shibli JA, Marcantonio E Jr, Marcantonio RAC, Galli GMT. Interleukin-1β and interleukin-6 expression and gene polymorphisms in subjects with peri-implant disease. Clin Implant Dent Relat Res 2011 [epub ahead of print].
47. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobauashi Y. Osteoclacin, deoxypyridinoline and interleukin-1b in periimplant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res 2002;13: 637-643.
48. Jin L, Söder B, Corbet EF. Interleukin-8 and granulocyte elastase in gingival crevicular fluid in relation to periodontopathogens in untreated adult periodontitis. J Periodontol 2000;71: 929-939.
49. Hou LT, Liu CM, Rossomando EF. Crevicular interleukin-Iβ in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 1995;22: 162-167.
50. Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid interleukin-1beta and interleukin-10 levels in chronic periodontitis. J Dent 2004;32: 511-520.
51. Duarte PM, de Mendoça AC, Máximo MB, Santos VR, Bastos MF, Nociti Junior FH. Differential cytokine expressions affect the severity of peri-implant disease. Clin Oral Implants Res 2009;20: 514-520.
52. Severino VO, Napimoga MH, de Lima Pereira SA. Expression of IL-6, IL-10, IL-17, and IL-8 in the peri-implant crevicular fluid of patients with periimplantitis. Arch Oral Biol 2011;56: 823-828.
53. Jin LJ, Sölder P-Ö, Leung WK, et al. Granulocyte elastase activity and PGE2 levels in gingival crevicular fluid in relation to the presence of subgingival periodontopathogens in subjects with untreated adult periodontitis. J Clin Periodontol 1999;26: 531-540.
54. Cox SW, Rodriguez-Gonzalez EM, Both V, Eley BM. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis. J Periodontal Res 2006;41: 477-485.
55. Nakamura-Minami M, Furuichi Y, Ishikawa K, Mitsuzono-Tofuku Y, Izumi Y. Changes in a1-protease inhibitor and secretory leukocyte protease inhibitor levels in gingival crevicular fluid before and after non-surgical periodontal treatment. Oral Dis 2003;9: 249-254.
56. Ashcroft GS, Lei K, Jin W, et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000;10: 1147-1153.